Events Calendar


Digital Event
/Portals/0/NADevEventsImages/Event Banner (8)_800.png

OBN CEO Interview: Getting to know David Loew, CEO of Ipsen

Event Start Date: 02/09/2021 12:30

Event End Date: 02/09/2021 13:30

We will also find out more about the culture that David is fostering at Ipsen, one focusing on entrepreneurship, agility and patient-centricity. 
John Harris will be digging a little deeper during the interview to understand whether Ipsen's R&D focus will remain with Oncology, Neuroscience and rare disease, or are there plans to move their research into other therapy areas and how strategic will the UK be in these future plans?
John will also be keen to understand David's views on some wider issues currently facing the life sciences industry, including whether large pharma organisations should re-invent their R&D models and move away from the traditional sequential, bottom-up process of target-based drug discovery to a more fully integrated, top down, systems-based approach?
Finally, we'll be keen to hear David's view on the post-pandemic regulatory landscape; now that we've seen much more flexibility & speed in approvals, how do we ensure this is continued on into the future?

About David Loew:
Prior to taking over the role of CEO at Ipsen in July 2020, David was CEO of Sanofi Pasteur Vaccines from 2016. During his tenure, he piloted a successful worldwide growth strategy via acquisitions and licensing deals. He also undertook a series of transformational initiatives: developing a global pipeline, reinforcing production strategy to strengthen compliance and increase capacity and building key programs to bring the company to best-practice level in talent acquisition, medical affairs, R&D productivity and shaping the external environment.
David brings nearly thirty years of leadership and experience across a range of therapeutic areas, including oncology, CNS and cardio-metabolism, as well as consumer healthcare. He has worked in the US, European and international markets. He started his career at Coopers & Lybrand and Hewlett Packard in 1990 before joining Roche in 1992. Over the following two decades, David held a variety of positions, including Global Oncology Head, Global Chief Marketing Officer & Head of Global Product Strategy and Region Head Eastern Europe, Middle East and Africa for the Pharma Division of Roche. He joined Sanofi in July 2013 as Senior Vice President Commercial Operations Europe, where he was responsible for the prescription, consumer healthcare and generics businesses across the EU region.

About the event:
This session will be delivered in live using Zoom Webinar, registration is open for both OBN Members and Non-Members. 

A live Q&A will follow the interview and audience members will be encouraged to send their questions in during the event.

OBN Members - Complimentary
Non-Members - £25+VAT

For all event enquiries, please contact: [email protected].

Return